A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
New perspectives in coronary heart disease management
2005
CARDIOVASCULAR THERAPY AND PREVENTION
Preserved Fulltext
The article is devoted to ACE inhibitor therapy in stable coronary heart disease (CHD). The author analyzes the results of multi-center trials on various ACE inhibitors' efficacy in decreasing risk of all-cause mortality, fatal and non-fatal myocardial infarction, stroke, chronic heart failure in CHD patients. ACE inhibitor efficacy in CHD is explained by the influence on endothelial dysfunction, thrombosis and inflammation factors, increased bradykinin synthesis and NO-synthase activity. A new
doaj:275ad4705a964e7f9f55be2c4efa3944
fatcat:dlfsq2wqjzcelig7hftp2mx3fy